Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivmecillinam for E. coli Bacteremic Urosepsis
NCT03282006Phase 4Completed
- Sponsor
- Sykehuset i Vestfold
- Start
- Sep 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pivmecillinam in urosepsis, pyelonephritis, sponsored by Sykehuset i Vestfold. Started Sep 2017; status: completed.
02
Drugs
pivmecillinam
03
Conditions
urosepsispyelonephritis
Beyond the preview
Go deeper on NCT03282006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282006.